Highlights in acute lymphoblastic leukemia (ALL) from ASH 2024 include significant results for blinatumomab in pediatric ALL, potential use of asciminib, and frontline use of CAR-T cell therapy.
Granulocytic sarcomas are rare ... can arise de novo or can be associated with other myeloid disorders -- acute myeloid leukemia (AML) or CML, myeloproliferative, or myelodysplastic conditions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback